Cancer and itch

Herbert C. Chiang, Victor Huang, Lynn A. Cornelius

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Itch represents a common and significant source of morbidity in the oncological setting. Itch sometimes can be associated with an underlying malignancy, most commonly leukemia or lymphoma. Alternatively, itch may present secondary to malignant invasion causing hepatic or renal dysfunction. Finally, itch may be related to therapeutic regimens for the underlying malignancy. This article seeks to review the clinical scenarios in which itch affects the oncological patient, to briefly present the latest understanding of the molecular and cellular mechanisms of malignancy-related itch, and to review currently available therapeutic options.

Original languageEnglish (US)
Pages (from-to)107-112
Number of pages6
JournalSeminars in Cutaneous Medicine and Surgery
Volume30
Issue number2
DOIs
StatePublished - Jun 1 2011
Externally publishedYes

Fingerprint

Neoplasms
Lymphoma
Leukemia
Morbidity
Kidney
Liver
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Cancer and itch. / Chiang, Herbert C.; Huang, Victor; Cornelius, Lynn A.

In: Seminars in Cutaneous Medicine and Surgery, Vol. 30, No. 2, 01.06.2011, p. 107-112.

Research output: Contribution to journalReview article

Chiang, Herbert C. ; Huang, Victor ; Cornelius, Lynn A. / Cancer and itch. In: Seminars in Cutaneous Medicine and Surgery. 2011 ; Vol. 30, No. 2. pp. 107-112.
@article{a5b2e0551f5b4e518e1a9780a14a6ffc,
title = "Cancer and itch",
abstract = "Itch represents a common and significant source of morbidity in the oncological setting. Itch sometimes can be associated with an underlying malignancy, most commonly leukemia or lymphoma. Alternatively, itch may present secondary to malignant invasion causing hepatic or renal dysfunction. Finally, itch may be related to therapeutic regimens for the underlying malignancy. This article seeks to review the clinical scenarios in which itch affects the oncological patient, to briefly present the latest understanding of the molecular and cellular mechanisms of malignancy-related itch, and to review currently available therapeutic options.",
author = "Chiang, {Herbert C.} and Victor Huang and Cornelius, {Lynn A.}",
year = "2011",
month = "6",
day = "1",
doi = "10.1016/j.sder.2011.05.003",
language = "English (US)",
volume = "30",
pages = "107--112",
journal = "Seminars in Cutaneous Medicine and Surgery",
issn = "1085-5629",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Cancer and itch

AU - Chiang, Herbert C.

AU - Huang, Victor

AU - Cornelius, Lynn A.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Itch represents a common and significant source of morbidity in the oncological setting. Itch sometimes can be associated with an underlying malignancy, most commonly leukemia or lymphoma. Alternatively, itch may present secondary to malignant invasion causing hepatic or renal dysfunction. Finally, itch may be related to therapeutic regimens for the underlying malignancy. This article seeks to review the clinical scenarios in which itch affects the oncological patient, to briefly present the latest understanding of the molecular and cellular mechanisms of malignancy-related itch, and to review currently available therapeutic options.

AB - Itch represents a common and significant source of morbidity in the oncological setting. Itch sometimes can be associated with an underlying malignancy, most commonly leukemia or lymphoma. Alternatively, itch may present secondary to malignant invasion causing hepatic or renal dysfunction. Finally, itch may be related to therapeutic regimens for the underlying malignancy. This article seeks to review the clinical scenarios in which itch affects the oncological patient, to briefly present the latest understanding of the molecular and cellular mechanisms of malignancy-related itch, and to review currently available therapeutic options.

UR - http://www.scopus.com/inward/record.url?scp=79960416737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960416737&partnerID=8YFLogxK

U2 - 10.1016/j.sder.2011.05.003

DO - 10.1016/j.sder.2011.05.003

M3 - Review article

VL - 30

SP - 107

EP - 112

JO - Seminars in Cutaneous Medicine and Surgery

JF - Seminars in Cutaneous Medicine and Surgery

SN - 1085-5629

IS - 2

ER -